Novitas Capital
Novitas Capital (formerly PA Early Stage Partners) is a venture capital firm that prospers because of their investment philosophy, their
Business Model:
Revenue: $11.2M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Novitas Capital Information
Geographic Data
Address: 435 Devon Park Drive Suite 801
City: Wayne
State: PA
Zip: 19087
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Novitas Capital ([formerly PA Early Stage Partners](http://novitascapital.com/news/novitas_20071114.html)) is a venture capital firm that prospers because of their investment philosophy, their strong partner relationships, and their team who carries significant hands-on experience in successfully guiding companies to growth and value creation. For more than a decade, Novitas Capital has successfully invested in and generated returns on early-stage technology and life science companies. At Novitas, they mine innovation and opportunities where funding for seed, start-up and early stage ventures is scarce. They discover companies at their earliest stages, thoroughly vet them and, upon typically leading investment rounds, take an active role in facilitating their success. The companies and ventures in which they invest are characterized by strong intellectual capital, proven leadership, breakthrough concepts, and unique positioning. Based in Wayne, Pennsylvania, with offices in Pittsburgh, Pennsylvania, Allendale, New Jersey, and Morgantown, West Virginia, Novitas currently has approximately 30 active portfolio companies and manages approximately $237 million across three venture funds.
Contact Phone:
+16102934075
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 3/2005 | Renal Solutions | Series B | 16.5M |
| 6/2007 | Logical Therapeutics | Series B | 30M |
| 7/2012 | Agile Therapeutics | Series C | 0 |
| 6/2010 | Agile Therapeutics | Series B | 0 |
| 8/2010 | TetraLogic Pharmaceuticals | Series C | 0 |
| 3/2010 | Nistica | Series C | 0 |
| 2/2011 | Nistica | Series D | 0 |
| 9/2004 | LifeShield | Series A | 6.6M |
| 5/2010 | Logical Therapeutics | Series C | 16.9M |
| 6/2000 | Investor Broadcast Network | Venture Round | 0 |
| 8/2000 | eonDigital | Venture Round | 4M |
| 2/2000 | iMedium | Series B | 7M |
| 7/2000 | iGrandparents.com | Series A | 3.3M |
| 7/2007 | Cellumen | Series B | 8.7M |
| 2/2008 | Nistica | Series B | 0 |
| 8/2016 | Cernostics | Equity | 5M |
| 12/2013 | Cernostics | Series B | 1.4M |
| 7/2004 | The Haley Enterprise | Series A | 5.5M |
| 6/2010 | Cernostics | Series A | 0 |
| 10/2009 | BPL Global | Venture Round | 0 |
| 4/2000 | Gazelle Systems | Series B | 4M |
| 4/2000 | EZ Prints | Venture Round | 2.7M |
| 10/2002 | SpeechVantage | Venture Round | - |
| 9/2000 | Wine Access | Venture Round | 3M |
| 8/2008 | BPL Global | Venture Round | 23M |
| 7/2011 | LifeShield | Venture Round | 0 |
| 1/2011 | TetraLogic Pharmaceuticals | Series C | 0 |
| 7/2000 | Magic Bean Stalk | Series A | 4.5M |
| 7/2013 | Cernostics | Venture Round | 1.4M |
| 6/2002 | EZ Prints | Venture Round | 0 |
| 2/2007 | BPL Global | Series C | 0 |
| 7/2000 | Internet Publishing Group | Venture Round | 5M |
| 1/2000 | Half.com | Venture Round | 17M |
| 3/2004 | iJET International | Series C | 0 |
| 6/2008 | TOA Technologies | Series C | 13M |
| 5/2000 | MedCases | Series A | 0 |
| 5/2007 | E-Duction | Venture Round | 7.5M |
| 7/2000 | Doctor Quality | Series B | 5M |
| 4/2005 | Ventaira Pharmaceuticals | Series C | 0 |
| 6/2001 | iJET International | Series B | 8.1M |
| 8/2009 | ClickEquations | Venture Round | 0 |
| 7/2007 | LifeShield | Series C | 0 |
| 8/2016 | Cernostics | Venture Round | 0 |
| 12/2013 | Cernostics | Series B | 0 |
| 7/2013 | Cernostics | Venture Round | 0 |
| 7/2012 | Agile Therapeutics | Series C | 0 |
| 7/2011 | LifeShield | Venture Round | 0 |
| 2/2011 | Nistica | Series D | 0 |
| 1/2011 | TetraLogic Pharmaceuticals | Series C | 0 |
| 8/2010 | TetraLogic Pharmaceuticals | Series C | 0 |
| 6/2010 | Agile Therapeutics | Series B | 0 |
| 6/2010 | Cernostics | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
